Sugathan P.R., who received two doses of Bharat Biotech's domestically developed Covaxin vaccine against the coronavirus disease (COVID-19), collects vegetables in his kitchen garden in Pandalam village, Kerala, India, October 22, 2021. REUTERS/Jose Devasia
PANDALAM, India (Reuters) - Stuck in a village in southern India for nine months and unable to return to his job in Saudi Arabia, Sugathan P.R. is hoping the World Health Organization will approve the Indian COVID-19 shot Covaxin, paving the way for his trip back.
Like Sugathan, millions of Indians have taken Covaxin and many have complained of travel struggles as the vaccine has not been recognised for international travel by several countries.
